Report on large shareholdings (general)
6.1
(주)에이프로젠
0000
20261114
Report on Large Holdings of Shares, etc.
| (General form: reports under Article 147 of the Financial Investment Services and Capital Markets Act with the purpose of influencing management control) |
| To: Financial Services Commission | Reporting obligation date: | 2026-11-14 |
| To: Korea Exchange | Report reference date: | 2026-11-20 |
| Reporting person: | (주)지베이스 |
| Summary |
| Issuer name | (주)에이프로젠 | Relationship to Issuer | Largest Shareholder |
| Report Type | 변동ㆍ변경 |
| Number of Shares Held and Holding Ratio | | Number of Shares Held | Holding Ratio |
| Previous Report | 102,430,390 | 85.61 |
| Current Report | 106,343,419 | 86.07 |
| Shares under key agreements: number and ratio | | Number of shares, etc. | Ratio |
| Previous Report | 18,638,097 | 15.58 |
| Current Report | 19,230,760 | 15.57 |
| Number of voting rights and holding ratio | | Number of Voting Rights | Holding Ratio |
| Previous Report | - | - |
| Current Report | - | - |
| Voting rights under key agreements: number and ratio | | Number of Voting Rights | Ratio |
| Previous Report | - | - |
| Current Report | - | - |
| Reason for Report | 보고자의 주식담보대출 계약 변경에 따른 보고전환가 조정에 따른 변동 및 계약 비율 변경 |
| ※ The reporting person confirms that holdings of shares, etc. by the reporting person and specially related parties as of the reference date are accurately stated per applicable laws and filing instructions, with no material misstatement or omission. |
Part 1 Report Overview
1. Issuer information
| Company Name | (주)에이프로젠 | Company code | 007460 |
| Entity type | KOSPI-listed company | Total Issued Voting Shares (shares) | 25,650,015 |
2. Major shareholder information
a. Reporting person
(1) Reporting person overview
| Report Type | 변동ㆍ변경 | Joint signatories |
| Reporting person type | Domestic corporation | Nationality | Republic of Korea |
| Basis for Reporter Classification (only if reported as a statutory partnership or other entity) | - |
| Name (Entity Name) | Korean | (주)지베이스 | Chinese characters (English) | G-BAISE Inc. |
| Address (Head Office) [Town/District Level Only] | 경기도 성남시 중원구 둔촌대로 545 | Date of Birth or Business Registration No., etc. | 129-86-85599 |
| Occupation (business) | 바이오의약품 연구, 개발 및 관련 컨설팅 | Relationship to Issuer | Largest Shareholder |
| Business contact and person in charge | Affiliated company | (주)지베이스 | Department | 경영관리팀 |
| Position | Manager | Phone Number | 031-80*** |
| Name | 김동규 | Fax number | 02-561* |
| Email address | **aprogen.com |
(2) 보고자에 대한 구체적인 사항(법인, 기타단체, 법령상조합, 민법상 조합의 경우 기재) (단위: 백만원)
| Legal form | Co., Ltd. |
| Total Assets (or Total Assets Under Management) | 77,426 | Total Liabilities | 123,439 |
| Total Equity | -46,013 | Paid-in Capital | 1,000 |
| Representative (representative or managing partner) | 강선주 |
| Decision-Making Body (Decision Maker) | Board of Directors |
| Largest Shareholder (Largest Investor) | (주)넥스코닉스 | Largest Shareholder Ownership (%) (Largest Investor Contribution Ratio) | 95.24 |
【보고자의 최대주주가 법인, 기타단체, 법령상조합, 민법상 조합의 경우】
| Legal form | Co., Ltd. |
| Total Assets (or Total Assets Under Management) | 21,370 | Total Liabilities | 3,921 |
| Total Equity | 17,449 | Paid-in Capital | 350 |
| Representative (representative or managing partner) | 유원형 |
| Decision-Making Body (Decision Maker) | Board of Directors |
| Largest Shareholder (Largest Investor) | (주)케이포르투나인베스트먼트 | Largest Shareholder Ownership (%) (Largest Investor Contribution Ratio) | 100.00 |
* 상기 자산총액, 부채총액, 자본총액 및 자본금 등은 2025년도말 기준 (단위:백만원)입니다.
b. Specially related parties
(1) Specially related party overview
| No. | Name | Category | Specific Relationship to Reporter | Date of Birth or Business Registration No., etc. | Nationality | Address (Location) | Occupation (Business) | Relationship to Issuer |
| 1 | (주)앱토크롬 | Domestic corporation | Affiliate | 114-81-82858 | Republic of Korea | 경기도 성남시중원구 둔촌대로 | 무선원격제어기 및 의약품유통 등 | Affiliates, etc. |
| 2 | (주)에이프로젠바이오로직스 | Domestic corporation | Affiliate | 218-81-00518 | Republic of Korea | 서울특별시 송파구 백제고분로 | 의약품 제조 등 | Affiliates, etc. |
| 3 | (주)넥스코닉스 | Domestic corporation | Affiliate | 107-88-32631 | Republic of Korea | 경기도 성남시중원구 둔촌대로 | Software development and supply | Affiliates, etc. |
| 4 | 김재섭 | Individual (Domestic) | Largest Shareholder | 630131 | Republic of Korea | 경기도 성남시 분당구 | 경영자 | Executive officers (registered) |
| 5 | 김정출 | Individual (Domestic) | Officer of Affiliate | 560511 | Republic of Korea | 경기도 성남시 분당구 | 경영자 | Officers of affiliates, etc. |
| 6 | 박미령 | Individual (Domestic) | Other | 650531 | Republic of Korea | 경기도 성남시 분당구 | - | Shareholder |
| 7 | 강선주 | Individual (Domestic) | CEO | 730625 | Republic of Korea | 경기도 의왕시 왕곡로 | 회사원 | Executive officers (registered) |
| 8 | 제이드신기술조합제79호 | 법령상 조합 | Other | 144-80-07926 | Republic of Korea | 경기도 성남시 분당구 성남대로 331 | - | Other |
| 9 | (주)엔투텍 | Domestic corporation | Affiliate | 759-88-00172 | Republic of Korea | 경기도 안성시 원곡면원당로 157 | 반도체 장비 부품 등 | Affiliates, etc. |
| 10 | 에이프로젠파마(주) | Domestic corporation | Affiliate | 143-81-17879 | Republic of Korea | 경기도 화성시 양감면 두머리길 18 | 의약품 도소매업 등 | Affiliates, etc. |
| * Address to town/district level only |
(2) Details of specially related parties (for corporations, other entities, statutory or civil-law partnerships)
- (주)에이프로젠바이오로직스 (단위 : 백만원,%)
| Legal form | Co., Ltd. |
| Total Assets (or Total Assets Under Management) | 586,993 | Total Liabilities | 309,426 |
| Total Equity | 277,567 | Paid-in Capital | 99,204 |
| Representative | 김재섭, 김정출 |
| Decision-Making Body (Decision Maker) | Board of Directors |
| Largest Shareholder (Largest Investor) | (주)에이프로젠 | Largest Shareholder Stake | 72.84 |
* 상기 자산총액, 부채총액, 자본총액 및 자본금은 2025년도말 연결기준금액입니다.* 상기 최대주주 지분율은 본 보고서 제출일 현재 기준 입니다.
- (주)앱토크롬 (
변경전:(주) 에이피헬스케어
) (단위 : 백만원,%)
| Legal form | Co., Ltd. |
| Total Assets (or Total Assets Under Management) | 320,455 | Total Liabilities | 13,886 |
| Total Equity | 306,569 | Paid-in Capital | 110,395 |
| Representative (representative or managing partner) | 김정출 |
| Decision-Making Body (Decision Maker) | Board of Directors |
| Largest Shareholder (Largest Investor) | (주)에이프로젠 | Largest Shareholder Ownership (%) (Largest Investor Contribution Ratio) | 52.28 |
* 상기 자산총액, 부채총액, 자본총액 및 자본금은 2025년도말 연결기준금액입니다.* 상기 최대주주 지분율은 본 보고서 제출일 현재 기준 입니다.
- (주)넥스코닉스 (단위 : 백만원,%)
| Legal form | Co., Ltd. |
| Total Assets (or Total Assets Under Management) | 21,370 | Total Liabilities | 3,921 |
| Total Equity | 17,449 | Paid-in Capital | 350 |
| Representative | 유원형 |
| Decision-Making Body (Decision Maker) | Board of Directors |
| Largest Shareholder (Largest Investor) | (주)케이포르투나인베스트먼트 | Largest Shareholder Stake | 100.00 |
* 상기 자산총액, 부채총액, 자본총액 및 자본금, 최대주주 지분율은 2025년도말 기준입니다.
- 제이드신기술조합 제79호
(Unit: KRW m, %)
| Legal form | 법령상조합 |
| Total Assets (or Total Assets Under Management) | 67,599 | Total Liabilities | 1,500 |
| Total Equity | 66,099 | Paid-in Capital | - |
| Representative (representative or managing partner) | (주)이스트게이트인베스트먼트 |
| Decision-Making Body (Decision Maker) | 조합원총회 |
| Largest Shareholder (Largest Investor) | (주)엔투텍 | Largest Shareholder Ownership (%) (Largest Investor Contribution Ratio) | 95.57 |
* 상기 자산총액, 부채총액, 자본총액 및 자본금, 최대주주 지분율은 2025년도말 기준입니다.- (주)엔투텍 (단위 : 백만원,%)
| Legal form | Co., Ltd. |
| Total Assets (or Total Assets Under Management) | 149,005 | Total Liabilities | 21,295 |
| Total Equity | 127,710 | Paid-in Capital | 17,254 |
| Representative (representative or managing partner) | 김재섭, 이욱재 |
| Decision-Making Body (Decision Maker) | Board of Directors |
| Largest Shareholder (Largest Investor) | 몬타나 신기술조합제72호 | Largest Shareholder Ownership (%) (Largest Investor Contribution Ratio) | 45.77 |
* 상기 자산총액, 부채총액, 자본총액 및 자본금은 2025년도말 연결기준금액입니다.* 상기 최대주주 지분율은 본 보고서 제출일 현재 기준 입니다.
- 에이프로젠파마(주) (단위 : 백만원,%)
| Legal form | Co., Ltd. |
| Total Assets (or Total Assets Under Management) | 49,153 | Total Liabilities | 97,338 |
| Total Equity | -48,185 | Paid-in Capital | 3,632 |
| Representative (representative or managing partner) | 김정출 |
| Decision-Making Body (Decision Maker) | Board of Directors |
| Largest Shareholder (Largest Investor) | (주)에이프로젠바이오로직스 | Largest Shareholder Ownership (%) (Largest Investor Contribution Ratio) | 100 |
* 상기 자산총액, 부채총액, 자본총액 및 자본금은 2025년도말 기준금액입니다.* 상기 최대주주 지분율은 본 보고서 제출일 현재 기준 입니다.
c. Collective investment manager
(Only if the reporting person or specially related party is a "collective investment vehicle" under Regulation Art. 3-10(2))
(1) Collective investment manager overview
| No. | Name | Business Registration No., etc. | Target collective investment vehicle | Nationality | Address (Location) | Remarks |
| - | - | - | - | - | - | - |
3. Shares, etc. held and holding ratio
| Report reference date | Reporting person | Shares, etc. | Share Certificates | Total Issued Voting Shares (shares) |
| Name of Holder | Number of Specially Related Persons | Number of Shares, etc. (shares) | Ratio (%) | Number of Shares (shares) | Ratio (%) |
| Previous Report | 2026.11.06 | (주)지베이스 | 11 | 102,430,390 | 85.61 | 8,445,081 | 32.92 | 25,650,015 |
| This Report | 2026.11.20 | (주)지베이스 | 11 | 106,343,419 | 86.07 | 8,445,081 | 32.92 | 25,650,015 |
| Change | 3,913,029 | 0.46 | 0 | 0 | 0 |
4. Purpose of holding
| Impact on management control |
| - 회사의 업무집행과 관련한 사항이 발생할 경우에는 관계법령 등에서 허용하는 범위 및 방법에 따라 회사의 경영목적에 부합하도록 주주로서 권리를 행사할 예정입니다.- 자본시장과 금융투자업에 관한 법률 시행령 제 154조 제1항 각 호 (아래1~10호)1. 임원의 선임ㆍ해임 또는 직무의 정지2. 이사회 등 회사의 기관과 관련된 정관의 변경3. 회사의 자본금의 변경4.<삭제>5. 회사의 합병, 분할과 분할합병6. 주식의 포괄적 교환과 이전7. 영업전부의 양수ㆍ도 또는 금융위원회가 정하여 고시하는 중요한 일부의 양수ㆍ도8. 자산 전부의 처분 또는 금융위원회가 정하여 고시하는 중요한 일부의 처분9. 영업전부의 임대 또는 경영위임, 타인과 영업의 손익 전부를 같이하는 계약, 그밖에 이에 준하는 계약의체결, 변경 또는 해약10. 회사의 해산 |
5. Reason for change
| Method of change | 전환가 조정에 따른 변동 |
| Reason for change | 전환가 조정에 따른 변동 |
| Reason for Change | 보고자의 주식담보대출 계약 변경에 따른 보고전환가 조정에 따른 계약 비율 변경 |
Part 2 Details of Large Holdings
1. Holdings by reporting person and specially related persons
A. Holdings by type of shares, etc.
| Relationship | Name | Date of Birth or Business Registration No., etc. | Details of Shares Held |
| Share certificates | Instruments representing preemptive rights | Convertible bonds | Bonds with warrants | Exchangeable bonds | Depositary receipts | Other | Total |
| Voting Shares | Shares Redeemable into Voting Shares | Shares Convertible into Voting Shares | Number of shares | Ratio (%) |
| Reporting person | (주)지베이스 | 129-86-85599 | 5,254,476 | - | - | - | - | - | - | - | - | 5,254,476 | 4.25 |
| Specially Related Party | (주)앱토크롬 | 114-81-82858 | - | - | - | - | 76,600,764 | - | - | - | - | 76,600,764 | 62.00 |
| (주)에이프로젠바이오로직스 | 218-81-00518 | - | - | - | - | - | - | - | - | - | - | - |
| (주)넥스코닉스 | 107-88-32631 | 1,764,694 | - | - | - | - | - | - | - | - | 1,764,694 | 1.43 |
| 김재섭 | 630131 | 888,533 | - | - | - | - | - | - | - | - | 888,533 | 0.72 |
| 김정출 | 560511 | 74,895 | - | - | - | - | - | - | - | - | 74,895 | 0.06 |
| 박미령 | 650531 | 449,271 | - | - | - | - | - | - | - | - | 449,271 | 0.36 |
| 강선주 | 730625 | 13,212 | - | - | - | - | - | - | - | - | 13,212 | 0.01 |
| 제이드신기술조합제79호 | 144-80-07926 | - | - | - | - | 13,201,639 | - | - | - | - | 13,201,639 | 10.69 |
| (주)엔투텍 | 759-88-00172 | - | - | - | - | 6,843,849 | - | - | - | - | 6,843,849 | 5.54 |
| 에이프로젠파마(주) | 143-81-17879 | - | - | - | - | 1,252,086 | - | - | - | - | 1,252,086 | 1.01 |
| A | a1 | a2 | B | C | D | E | F | G | | |
| H |
| Total Issued Voting Shares (I) | Number of Potential Shares Held (a1+a2+B+C+D+E+F+G=H) | Holding Ratio (%) |
| Holding Ratio of Shares, etc. [A+H / I+H-(E+F+G)※] × 100 | Share Holding Ratio (A / I) × 100 |
| 25,650,015 | 97,898,338 | 86.07 | 32.92 |
※ Holding ratio calculated excluding from the denominator only exchangeable bonds exchangeable into shares, depositary receipts and derivative-linked securities with shares as underlying, and stock options settled in treasury shares
B. Holdings by form of holding
| Relationship | Name (Entity Name) | Date of Birth or Business Registration No., etc. | Type of holding equivalent to ownership (Article 142, Enforcement Decree of the Financial Investment Services and Capital Markets Act) | Total |
| No. 1 | No. 2 | No. 3 | No. 4 | No. 5 | No. 6 | No. 7 | Number of shares | Ratio |
| Reporting person | (주)지베이스 | 129-86-85599 | 5,254,476 | - | - | - | - | - | - | 5,254,476 | 4.25 |
| Specially Related Party | (주)앱토크롬 | 114-81-82858 | 76,600,764 | - | - | - | - | - | - | 76,600,764 | 62.00 |
| (주)에이프로젠바이오로직스 | 218-81-00518 | - | - | - | - | - | - | - | - | - |
| (주)넥스코닉스 | 107-88-32631 | 1,764,694 | - | - | - | - | - | - | 1,764,694 | 1.43 |
| 김재섭 | 630131 | 888,533 | - | - | - | - | - | - | 888,533 | 0.72 |
| 김정출 | 560511 | 74,895 | - | - | - | - | - | - | 74,895 | 0.06 |
| 박미령 | 650531 | 449,271 | - | - | - | - | - | - | 449,271 | 0.36 |
| 강선주 | 730625 | 13,212 | - | - | - | - | - | - | 13,212 | 0.01 |
| 제이드신기술조합제79호 | 144-80-07926 | 13,201,639 | - | - | - | - | - | - | 13,201,639 | 10.69 |
| (주)엔투텍 | 759-88-00172 | 6,843,849 | - | - | - | - | - | - | 6,843,849 | 5.54 |
| 에이프로젠파마(주) | 143-81-17879 | 1,252,086 | - | - | - | - | - | - | 1,252,086 | 1.01 |
| ※ Holdings equivalent to ownership (Article 142, Enforcement Decree of the Financial Investment Services and Capital Markets Act) - Item 1: owning shares, etc. for one's own account, in whatever name - Item 2: holding a right to claim delivery of shares, etc. under law, a sale, or other contract - Item 3: holding voting rights (including the right to direct voting) over the shares, etc. under law, a money trust, security, or other contract - Item 4: holding the authority to acquire or dispose of the shares, etc. under law, a money trust, security, discretionary investment, or other contract - Item 5: acquiring, through a unilateral reservation for sale of shares, etc., the right to complete the sale, and holding buyer status by exercising that right - Item 6: holding contractual rights under Article 5(1)(2) of the Act with shares, etc. as underlying assets, and holding buyer status by exercising those rights - Item 7: being granted stock options and holding buyer status by exercising them |
2. Contracts on shares held
A. Contract status
| Execution or amendment of key agreements (trust, collateral, lending, discretionary, OTC trading, joint holding, etc.) |
| Yes |
*Voting rights on unreported holdings may be restricted if execution/amendment of material contracts is not reported
B. Contract details
| No. | Name (Entity Name) | Relationship to Reporter | Date of Birth or Business Registration No., etc. | Type of shares, etc. | Number of shares, etc. | Counterparty | Contract type | Contract date (amendment date) | Contract period | Ratio | Remarks |
| 1 | (주)지베이스 | Self | 129-86-85599 | Voting Shares | 666,666 | (주)투파스 | 담보계약 | 2026.10.30 | 2027.04.30 | 0.54 | 주식담보 |
| 2 | (주)지베이스 | Self | 129-86-85599 | Voting Shares | 155,440 | 에이프로젠아이앤씨(주) | 담보계약 | 2025.07.22 | 상환시 | 0.13 | 주식담보 |
| 3-1 | (주)지베이스 | Self | 129-86-85599 | Voting Shares | 693,284 | (주)에이프로젠바이오로직스 | 담보계약 | 2025.07.23 | 상환시 | 0.56 | 주식담보 |
| 3-2 | 김재섭 | Related party | 630131 | Voting Shares | 888,533 | (주)에이프로젠바이오로직스 | 담보제공계약 | 2023.02.17 | 상환시 | 0.72 | 주식담보 |
| 3-3 | (주)지베이스 | Self | 129-86-85599 | Voting Shares | 449,271 | (주)에이프로젠바이오로직스 | 담보계약 | 2025.07.22 | 상환시 | 0.36 | 주식담보 |
| 3-4 | (주)지베이스 | Self | 129-86-85599 | Voting Shares | 333,333 | (주)에이프로젠바이오로직스 | 담보계약 | 2024.11.19 | 상환시 | 0.27 | 주식담보 |
| 4 | (주)앱토크롬 | Related party | 114-81-82858 | Convertible bonds | 2,635,740 | 임정연 | 전환사채양수도계약 | 2026.09.30 | 2027.03.31 | 2.13 | 29CB 일부 |
| 5 | (주)앱토크롬 | Related party | 114-81-82858 | Convertible bonds | 5,271,481 | (주)투파스 | 전환사채양수도계약 | 2026.09.30 | 2027.03.31 | 4.27 | 29CB 일부 |
| 6 | (주)지베이스 | Self | 129-86-85599 | Voting Shares | 833,333 | 블루케이대부 | 담보계약 | 2026.09.23 | 2027.03.27 | 0.67 | 주식담보 |
| 7 | (주)앱토크롬 | Related party | 114-81-82858 | Convertible bonds | 5,012,531 | (주)하베스트로즈 | 전환사채양수도계약 | 2026.07.21 | 2026.12.31 | 4.06 | 27CB |
| 8 | (주)넥스코닉스 | Related party | 107-88-32631 | Voting Shares | 140,000 | 수원지방법원성남지원 | 공탁 | 2024.11.15 | 공탁해지시 | 0.11 | 납세담보 |
| 9 | (주)넥스코닉스 | Related party | 107-88-32631 | Voting Shares | 24,000 | 수원지방법원성남지원 | 공탁 | 2025.05.08 | 공탁해지시 | 0.02 | 납세담보 |
| 10 | (주)지베이스 | Self | 129-86-85599 | Voting Shares | 800,000 | (주)온리홀딩스대부 | 담보계약 | 2026.11.06 | 2027.05.08 | 0.65 | 주식담보 |
| 11 | (주)지베이스 | Self | 129-86-85599 | Voting Shares | 300,000 | (주)온리홀딩스대부 | 담보계약 | 2026.11.14 | 2027.05.14 | 0.24 | 주식담보 |
| 12 | 제이드신기술조합제79호 | Related party | 144-80-07926 | Convertible bonds | 527,148 | 권은자 | 전환사채 매매 계약 | 2026.05.18 | 2026.12.31 | 0.43 | 25CB 일부 |
| 13 | (주)지베이스 | Self | 129-86-85599 | Voting Shares | 500,000 | (주)제이와이케이홀딩스 | 담보계약 | 2026.07.20 | 2027.07.19 | 0.41 | 주식담보 |
| Total (number of shares, etc.) | 19,230,760 | Total (ratio) | 15.57 | - |
C. Additional details if the main contract is a security agreement
| No. | Number of shares, etc. | Loan amount | Debtor | Interest rate | Collateral maintenance ratio | Other |
| 1 | 666,666 | 1,700,000,000 | (주)지베이스 | 6.2 | 140 | - |
| 2 | 155,440 | 3,000,000,000 | (주)지베이스 | 4.0 | 150 | - |
| 3 | 2,364,421 | 37,200,000,000 | (주)지베이스 | 4.0 | 150 | - |
| 6 | 833,333 | 3,400,000,000 | (주)지베이스 | 6.0 | 150 | - |
| 10 | 800,000 | 2,000,000,000 | (주)지베이스 | 6.5 | 150 | - |
| 11 | 300,000 | 1,000,000,000 | (주)지베이스 | 6.5 | 150 | - |
| 13 | 500,000 | 1,000,000,000 | (주)지베이스 | 6.5 | - | - |
3. Holdings by proprietary and customer account (financial institutions only)
| Name | Relationship to Reporter | By account | Total |
| Own Account (shares) | Ratio (%) | Customer account (shares) | Ratio (%) | Total (shares) | Ratio (%) |
| - | - | - | - | - | - | - | - |
| Total | - | - | - | - | - | - |
Part 3 Material Changes Since Last Report Date
1. Summary of changes
a. Changes in shares, etc.
| Relationship | Name | Date of Birth or Business Registration No., etc. | Details of Changes in Shares, etc. |
| Share certificates | Instruments representing preemptive rights | Convertible bonds | Bonds with warrants | Exchangeable bonds | Depositary receipts | Other | Total |
| Voting Shares | Shares Redeemable into Voting Shares | Shares Convertible into Voting Shares | Number of shares | Ratio (%) |
| Reporting person | (주)지베이스 | 129-86-85599 | - | - | - | - | - | - | - | - | - | - | -0.14 |
| Specially Related Party | (주)앱토크롬 | 114-81-82858 | - | - | - | - | 3,147,872 | - | - | - | - | 3,147,872 | 0.6 |
| (주)에이프로젠바이오로직스 | 218-81-00518 | - | - | - | - | - | - | - | - | - | - | - |
| (주)넥스코닉스 | 107-88-32631 | - | - | - | - | - | - | - | - | - | - | -0.05 |
| 김재섭 | 630131 | - | - | - | - | - | - | - | - | - | - | -0.02 |
| 김정출 | 560511 | - | - | - | - | - | - | - | - | - | - | - |
| 박미령 | 650531 | - | - | - | - | - | - | - | - | - | - | -0.02 |
| 강선주 | 730625 | - | - | - | - | - | - | - | - | - | - | - |
| 제이드신기술조합제79호 | 144-80-07926 | - | - | - | - | 765,157 | - | - | - | - | 765,157 | 0.3 |
| (주)엔투텍 | 759-88-00172 | - | - | - | - | - | - | - | - | - | - | -0.18 |
| 에이프로젠파마(주) | 143-81-17879 | - | - | - | - | - | - | - | - | - | - | -0.03 |
2. Change details
a. Detailed changes in shares, etc.
| Name (Entity Name) | Date of Birth or Business Registration No., etc. | Change Date* | Acquisition/disposal method | Type of shares, etc. | Change details | Acquisition/disposal unit price** | Remarks |
| Before Change | Change | After Change |
| (주)앱토크롬 | 114-81-82858 | 2026.11.14 | 행사가액조정 | Convertible bonds | 73,452,892 | 2,417,495 | 75,870,387 | 1,897 | () | 29cb 전환가 조정2,041원 ==> 1,897원 |
| (주)앱토크롬 | 114-81-82858 | 2026.11.15 | 행사가액조정 | Convertible bonds | 75,870,387 | 730,377 | 76,600,764 | 1,897 | () | 25cb 전환가 조정2,031원 ==> 1,897원 |
| 제이드신기술조합제79호 | 144-80-07926 | 2026.11.15 | 행사가액조정 | Convertible bonds | 12,436,482 | 765,157 | 13,201,639 | 1,897 | () | 25cb 전환가 조정2,031원 ==> 1,897원 |
* For trades on the securities market, the contract date
** For securities other than shares, the exercise (conversion/exchange) price of the securities or the unit price of shares acquired/disposed of through exercise of rights; amounts in ( ) are the unit price of the securities
3. Source of acquisition funds
(1) Overview of acquisition funds
| Name | Date of birth or business registration no., etc. | Own funds (H) | Borrowings (I) | Other (J) | Total (H+I+J) |
| - | - | - | - | - | - |
(2) Origin and source of acquisition funds